Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Cancer Med. 2021 Dec;10(24):9000-9011. doi: 10.1002/cam4.4364. Epub 2021 Dec 1.
We determined the prevalence of current cigarette smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer in Japan and compared the findings with nationally representative studies in other countries.
We conducted a cross-sectional study of baseline data from a prospective cohort study. A self-administered questionnaire was surveyed during 2013-2015 with residents aged ≥20 years attending a community-based cardiometabolic screening program in Miyagi prefecture in north-eastern Japan. Subjects with past cancer histories were classified as cancer survivors. Sex-specific, age-standardized prevalence of current smokers, and drinkers were calculated. Age-adjusted prevalence ratios (PRs: the cancer survivors' rate divided by the rate of subjects with no history of cancer) and 95% confidence intervals (CIs) were estimated with log-binomial regressions.
36,786 subjects, including 2760 cancer survivors, responded and provided usable information (58.9% of recruited subjects). For men, the age-standardized prevalence of current smokers and drinkers among survivors was 18.8% and 74.4%, respectively, with an age-adjusted PR (95%CI) of 0.76 (0.66-0.86, p < 0.001) and 0.95 (0.91-0.98, p = 0.002), respectively. For women, the figures were 6.1%, 37.9%, 0.84 (0.67-1.06, p = 0.138) and 0.96 (0.90-1.03, p = 0.313), respectively. The U.S., the U.K, and Australian studies generally showed no substantially lower prevalence of current smokers or drinkers in survivors than in subjects with no history of cancer (PR ≥ 0.75), while Korean studies did (PR < 0.75).
A considerable proportion of Japanese cancer survivors, especially men, remained currently smoking and drinking. Consistent with Western studies, the rates were not substantially lower than those among subjects with no history of cancer.
我们确定了日本癌症幸存者和无癌症史人群中当前吸烟者和饮酒者的流行率,并将这些发现与其他国家的全国代表性研究进行了比较。
我们对一项前瞻性队列研究的基线数据进行了横断面研究。2013 年至 2015 年期间,在日本东北部宫城县的社区心血管代谢筛查计划中,对年龄≥20 岁的居民进行了自我管理的问卷调查。有过去癌症病史的受试者被归类为癌症幸存者。计算了男性和女性的当前吸烟者和饮酒者的年龄标准化流行率。使用对数二项式回归估计了年龄调整后的患病率比(PR:癌症幸存者的比率除以无癌症史人群的比率)及其 95%置信区间(CI)。
共有 36786 名受试者,包括 2760 名癌症幸存者,做出了回应并提供了可用信息(占招募受试者的 58.9%)。对于男性,幸存者中当前吸烟者和饮酒者的年龄标准化流行率分别为 18.8%和 74.4%,年龄调整后的 PR(95%CI)分别为 0.76(0.66-0.86,p<0.001)和 0.95(0.91-0.98,p=0.002)。对于女性,这两个数字分别为 6.1%、37.9%、0.84(0.67-1.06,p=0.138)和 0.96(0.90-1.03,p=0.313)。美国、英国和澳大利亚的研究通常表明,癌症幸存者中当前吸烟者或饮酒者的比例与无癌症史人群相比没有明显降低(PR≥0.75),而韩国的研究则表明情况并非如此(PR<0.75)。
相当一部分日本癌症幸存者,尤其是男性,仍然存在当前吸烟和饮酒的情况。与西方研究一致,这些比率并没有明显低于无癌症史人群。